Article2010

Multiple sclerosis risk sharing scheme: a costly failure

Unknown author

89 citations0/0 files storedBMJ

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Multiple Sclerosis Research Studies Health Systems, Economic Evaluations, Quality of Life

Abstract

The NHS is paying for thousands of patients with multiple sclerosis to receive drugs that monitoring data suggest are not effective. James Raftery examines what went wrong with the access scheme that facilitated their use

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 89 citations exist upstream.

Cited by

2019Performance-based managed entry agreements for new medicines in OECD countries and EU member states 2011Value-Based Pricing 2012Reflections on the evolution of health technology assessment in Europe

Imported from OpenAlex (CC0) — nothing here is generated.